Sign up
Quantellect · Congress · Trade Detail
PCLNThe Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch)
RepublicanHouse

K. Michael Conaway bought The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) (PCLN)

K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 4 trades in The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) (PCLN) since 2015, 3 purchases and 1 sale, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: K. Michael Conaway bought $1,001 - $15,000 of The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) (PCLN) on November 6, 2015. Since that trade, PCLN is up +15.78% against the S&P 500 up +313.34%, an outperformance of -297.57%.

Across these filings, K. Michael Conaway has been a net buyer of PCLN (a buy-to-sell ratio of 3.00). The most recent disclosed PCLN transaction shown was dated September 12, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PCLN trades
4
Disclosed Vol
$32K
Buys
3
75%
Sells
1
25%
Buy / Sell
3.00
ratio
First → Last
2015–2016

K. Michael Conaway's PCLN trades vs the price

PCLN is up +15.78% since K. Michael Conaway bought on November 6, 2015, versus +313.34% for the S&P 500.

Performance since this trade

Price change since trade
+15.78%
S&P 500 change since trade
+313.34%
Outperformance vs S&P 500
-297.57%

All K. Michael Conaway PCLN trades

TradedTypeSizeReturnEst. profit
September 12, 2016SELL$1,001 - $15,000N/A
August 17, 2016BUY$1,001 - $15,000N/A
November 6, 2015BUY$1,001 - $15,000N/A
February 9, 2015BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

K. Michael Conaway & PCLN trading FAQ

Is it legal for K. Michael Conaway to trade The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) (PCLN) stock?

Yes. Members of Congress are allowed to trade individual stocks, including The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) (PCLN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did K. Michael Conaway buy PCLN?

K. Michael Conaway disclosed a purchase of $1,001 - $15,000 of The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) (PCLN) on November 6, 2015, according to public STOCK Act filings.

How has PCLN performed since K. Michael Conaway's trade?

Since K. Michael Conaway bought PCLN on November 6, 2015, the stock is up +15.78%, versus +313.34% for the S&P 500 over the same period, an outperformance of -297.57%.

How many times has K. Michael Conaway traded PCLN?

K. Michael Conaway has disclosed 4 PCLN trades since 2015 (3 purchases and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PCLN trades?

Quantellect tracks every disclosed congressional trade in The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) (PCLN) on the The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch) congressional trading page, which aggregates filings across all members of Congress.

K. Michael Conaway's PCLN tradesAll congressional filings for The Priceline group Inc. (PCLN) F ILINg s TATUs : New s UbHoLDINg o F : sP M81 (Merrill Lynch)K. Michael Conaway's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.